Production and characterization of anti-hypertensive and anti-diabetic peptides from fermented sheep milk with anti-inflammatory activity: in vitro and molecular docking studies
- PMID: 38855927
- DOI: 10.1002/jsfa.13617
Production and characterization of anti-hypertensive and anti-diabetic peptides from fermented sheep milk with anti-inflammatory activity: in vitro and molecular docking studies
Abstract
Background: The present study aimed to evaluate the anti-hypertensive and anti-diabetic activities from biologically active peptides produced by fermented sheep milk with Lacticaseibacillus paracasei M11 (MG027695), as well as to purify and characterize the angiotensin-converting enzyme (ACE) inhibitory and anti-diabetic peptides produced from fermented sheep milk.
Results: After 48 h of fermentation at 37 °C, sheep milk demonstrated significant changes in anti-diabetic effects and ACE-I effects, with inhibition percentages observed for ACE inhibition (76.32%), α-amylase (70.13%), α-glucosidase (70.11%) and lipase inhibition (68.22%). The highest level of peptides (9.77 mg mL-1) was produced by optimizing the growth conditions, which included an inoculation rate of 2.5% and a 48 h of incubation period. The comparison of molecular weight distributions among protein fractions was conducted through sodium dodecyl-sulfate polyacrylamide gel electrophoresis analysis, whereas spots were separated using 2D gel electrophoresis according to both the molecular weight and pH. Peptide characterization with ultra-filtration membranes at 3 and 10 kDa allowed the study to assess molecular weight-based separation. Nitric oxide generated by lipopolysaccharide and the secretion of pro-inflammatory cytokines in RAW 264.7 immune cells were both inhibited by sheep milk fermented with M11. Fourier-transform infrared spectroscopy was employed to assess changes in functional groups after fermentation, providing insights into the structural changes occurring during fermentation.
Conclusion: The present study demonstrates that fermentation with L. paracasei (M11) led to significant changes in fermented sheep milk, enhancing its bioactive properties, notably in terms of ACE inhibition and anti-diabetic activities, and the generation of peptides with bioactive properties has potential health benefits. © 2024 Society of Chemical Industry.
Keywords: ACE‐inhibitory activity; CLSM; FTIR; LAB; RP‐HPLC; SDS; anti‐diabetic activity; bioactive peptide; fermented sheep milk.
© 2024 Society of Chemical Industry.
References
REFERENCES
-
- Padhi S, Chourasia R, Kumari M, Singh SP and Rai AK, Production and characterization of bioactive peptides from rice beans using Bacillus subtilis. Bioresour Technol 351:126932 (2022).
-
- Dario C, Carnicella D, Dario M and Bufano G, Genetic polymorphism of β‐lactoglobulin gene and effect on milk composition in Leccese sheep. Small Rumi Res 74:270–273 (2008).
-
- Selvaggi M, Laudadio V, Dario C and Tufarelli V, Investigating the genetic polymorphism of sheep milk proteins: a useful tool for dairy production. J Sci Food Agric 94:3090–3099 (2014).
-
- Raveschot C, Cudennec B, Coutte F, Flahaut C, Fremont M, Drider D et al., Production of bioactive peptides by Lactobacillus species: from gene to application. Front Microbiol 9:2354 (2018).
-
- Dimidi E, Cox SR, Rossi M and Whelan K, Fermented foods: definitions and characteristics, impact on the gut microbiota and effects on gastrointestinal health and disease. Nutrients 11:1806 (2019).
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous